The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 04, 2025

Filed:

Jun. 27, 2017
Applicant:

Samsung Life Public Welfare Foundation, Seoul, KR;

Inventors:

Yun Sil Chang, Seoul, KR;

Won Soon Park, Seoul, KR;

Dong Kyung Sung, Seoul, KR;

So Yoon Ahn, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/48 (2006.01); A61K 9/12 (2006.01); A61K 9/70 (2006.01); A61K 35/28 (2015.01); A61P 17/02 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4833 (2013.01); A61K 9/12 (2013.01); A61K 9/70 (2013.01); A61K 35/28 (2013.01); A61P 17/02 (2018.01);
Abstract

The present disclosure relates to a pharmaceutical composition comprising an exosome derived from a thrombin-treated stem cell as an effective ingredient for preventing or treating a skin wound, a pharmaceutical formulation containing the same, and a production method thereof. Being a cell-free agent, an exosome-based therapeutic agent of the present disclosure has a low risk of carcinogenesis and no problems of graft rejection as well as being little liable to occur microvascular obstruction. The agent, which is not a cell, but a material isolated from a cell, can be subjected to medication development into an off-the-shelf product which allows for the reduction of production cost. The agent has the advantage of exhibiting outstanding angiogenesis and skin wound treatment effects even at a low concentration of exosomes thanks to the thrombin treatment effect.


Find Patent Forward Citations

Loading…